210 related articles for article (PubMed ID: 34845370)
1. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
Li X; Hou P; Ma W; Wang X; Wang H; Yu Z; Chang H; Wang T; Jin S; Wang X; Wang W; Zhao Y; Zhao Y; Xu C; Ma X; Gao Y; He H
Cell Mol Immunol; 2022 Jan; 19(1):67-78. PubMed ID: 34845370
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
4. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
Yu M; Li J; Gao W; Li Z; Zhang W
J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
Schindewolf C; Lokugamage K; Vu MN; Johnson BA; Scharton D; Plante JA; Kalveram B; Crocquet-Valdes PA; Sotcheff S; Jaworski E; Alvarado RE; Debbink K; Daugherty MD; Weaver SC; Routh AL; Walker DH; Plante KS; Menachery VD
J Virol; 2023 Feb; 97(2):e0153222. PubMed ID: 36722972
[TBL] [Abstract][Full Text] [Related]
7. The Interaction between SARS-CoV-2 Nucleocapsid Protein and UBC9 Inhibits MAVS Ubiquitination by Enhancing Its SUMOylation.
Huang C; Yin Y; Pan P; Huang Y; Chen S; Chen J; Wang J; Xu G; Tao X; Xiao X; Li J; Yang J; Jin Z; Li B; Tong Z; Du W; Liu L; Liu Z
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140545
[TBL] [Abstract][Full Text] [Related]
8. The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response.
van Huizen M; Vendrell XM; de Gruyter HLM; Boomaars-van der Zanden AL; van der Meer Y; Snijder EJ; Kikkert M; Myeni SK
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400032
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD
Front Immunol; 2021; 12():679482. PubMed ID: 34177923
[TBL] [Abstract][Full Text] [Related]
10. Activation of NIX-mediated mitophagy by an interferon regulatory factor homologue of human herpesvirus.
Vo MT; Smith BJ; Nicholas J; Choi YB
Nat Commun; 2019 Jul; 10(1):3203. PubMed ID: 31324791
[TBL] [Abstract][Full Text] [Related]
11. Tegument protein UL3 of bovine herpesvirus 1 suppresses antiviral IFN-I signaling by targeting STING for autophagic degradation.
Sun F; Ma W; Wang H; He H
Vet Microbiol; 2024 Apr; 291():110031. PubMed ID: 38412580
[TBL] [Abstract][Full Text] [Related]
12. Viperin interacts with PEX19 to mediate peroxisomal augmentation of the innate antiviral response.
Khantisitthiporn O; Shue B; Eyre NS; Nash CW; Turnbull L; Whitchurch CB; Van der Hoek KH; Helbig KJ; Beard MR
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34108265
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection and the antiviral innate immune response.
Yang H; Lyu Y; Hou F
J Mol Cell Biol; 2020 Nov; 12(12):963-967. PubMed ID: 33377937
[No Abstract] [Full Text] [Related]
14. Nlrp6 protects from corticosterone-induced NSPC ferroptosis by modulating RIG-1/MAVS-mediated mitophagy.
Shen J; Xie P; Wang J; Yang F; Li S; Jiang H; Wu X; Zhou F; Li J
Redox Biol; 2024 Jul; 73():103196. PubMed ID: 38772149
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and UPS with potentials for therapeutic interventions.
Ferdoush J; Abdul Kadir R; Simay Kaplanoglu S; Osborn M
Gene; 2024 Jun; 912():148377. PubMed ID: 38490508
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19.
Guarnieri JW; Haltom JA; Albrecht YES; Lie T; Olali AZ; Widjaja GA; Ranshing SS; Angelin A; Murdock D; Wallace DC
Pharmacol Res; 2024 Jun; 204():107170. PubMed ID: 38614374
[TBL] [Abstract][Full Text] [Related]
17. RNF5: inhibiting antiviral immunity and shaping virus life cycle.
Ge J; Zhang L
Front Immunol; 2023; 14():1324516. PubMed ID: 38250078
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.
Mhlekude B; Postmus D; Stenzel S; Weiner J; Jansen J; Zapatero-Belinchón FJ; Olmer R; Richter A; Heinze J; Heinemann N; Mühlemann B; Schroeder S; Jones TC; Müller MA; Drosten C; Pich A; Thiel V; Martin U; Niemeyer D; Gerold G; Beule D; Goffinet C
PLoS Pathog; 2023 Sep; 19(9):e1011657. PubMed ID: 37747932
[TBL] [Abstract][Full Text] [Related]
19.
Xu Z; Tian M; Tan Q; Hao P; Gao Z; Li C; Jin N
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203523
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus.
Buskiewicz IA; Montgomery T; Yasewicz EC; Huber SA; Murphy MP; Hartley RC; Kelly R; Crow MK; Perl A; Budd RC; Koenig A
Sci Signal; 2016 Nov; 9(456):ra115. PubMed ID: 27899525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
